GENETICS OF DEMENTIA: THE CANDIDATE GENES AND AVAILABLE GENETIC TESTINGS

Authors

  • Ziske Maritska Universitas Sriwijaya, Indonesia
  • Diah Andini Universitas Sriwijaya, Indonesia
  • Febryana Ramadhani Machyar Universitas Sriwijaya, Indonesia
  • Rachmat Taufan Universitas Sriwijaya, Indonesia
  • Try Merdeka Puri Universitas Sriwijaya, Indonesia
  • Tryvanie R Putra Universitas Sriwijaya, Indonesia
  • Uswati Uswati Universitas Sriwijaya, Indonesia
  • Bintang Arroyantri Prananjaya Universitas Sriwijaya, Indonesia
  • Rini Nindela Universitas Sriwijaya, Indonesia
  • Nita Parisa Universitas Sriwijaya, Indonesia

DOI:

https://doi.org/10.24269/ijhs.v7i2.6353

Abstract

When dementia is present, a person's memory, reasoning, behavior, and even their capacity to carry out day-to-day chores can all become distorted. This syndrome remains present and actually worsens as time passes. It's possible that synapse loss, death and dysfunction of brain cells, gliosis, and inflammation are all factors in the progression of dementia. The clinical syndrome, age, and a history of the ailment in the patient's family should dictate the choices made about counseling and testing. Dementia is known as a multifactorial condition, brought on by the combination of strong genetic factors and environmental factors. There are several candidate genes  associated with Dementia; APP, PSEN1, and PSEN2 genes, in addition to the GRN and MAPT genes. This literatura review provide insight on the genetic of Dementia, particularly in the genetic causes and testings

Downloads

Download data is not yet available.

References

[1] Louis ED; Mayer SA; Rowland LP. Merritt’s neurology. New York: Lippincott Williams & Wilkins; 2016.
[2] Aarsland D. Epidemiology and Pathophysiology of Dementia-Related Psychosis. J Clin Psychiatry. September 2020;81(5).
[3] Falk N, Cole A, Meredith TJ. Evaluation of Suspected Dementia. Am Fam Physician. Maret 2018;97(6):398–405.
[4] Tisher A, Salardini A. A Comprehensive Update on Treatment of Dementia. Semin Neurol. April 2019;39(2):167–78.
[5] Arvanitakis Z, Shah RC, Bennett DA. Diagnosis and Management of Dementia: Review. JAMA. Oktober 2019;322(16):1589–99.
[6] American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Arlington VA: American Psychiatric Association; 2013.
[7] Mansfield E, Noble N, Sanson-Fisher R, Mazza D, Bryant J. Primary Care Physicians’ Perceived Barriers to Optimal Dementia Care: A Systematic Review. Gerontologist. November 2019;59(6):e697–708.
[8] Devenney EM, Ahmed RM, Hodges JR. Frontotemporal dementia. Handb Clin Neurol. 2019;167:279–99.
[9] Huq AJ, Sexton A, Lacaze P, Masters CL, Storey E, Velakoulis D, et al. Genetic testing in dementia-A medical genetics perspective. Int J Geriatr Psychiatry.Agustus 2021;36(8):1158–70.
[10]Koriath CAM, Kenny J, Ryan NS, Rohrer JD, Schott JM, Houlden H, et al. Genetic testing in dementia — utility and clinical strategies. Nat Rev Neurol [Internet]. 2021;17(1):23–36. Tersedia pada: https://doi.org/10.1038/s41582-020-00416-1

[11] Zetterberg H, van Swieten JC, Boxer AL, Rohrer JD. Review: Fluid biomarkers for frontotemporal dementias. Neuropathol Appl Neurobiol. Februari 2019;45(1):81–7.
[12] Hsu J-L, Lin C-H, Chen P-L, Lin K-J, Chen T-F. Genetic study of young-onset dementia using targeted gene panel sequencing in Taiwan. Am J Med Genet Part B, Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet. Maret 2021;186(2):67–76.
[13]Fenoglio C, Scarpini E, Serpente M, Galimberti D. Role of Genetics and Epigenetics in the Pathogenesis of Alzheimer’s Disease and Frontotemporal Dementia. J Alzheimers Dis. 2018;62(3):913–32.
[14] Gale SA, Acar D, Daffner KR. Dementia. Am J Med. Oktober 2018;131(10):1161–9.
[15] Elahi FM, Miller BL. A clinicopathological approach to the diagnosis of dementia. Nat Rev Neurol. Agustus 2017;13(8):457–76.
[16] Bellou V, Belbasis L, Tzoulaki I, Middleton LT, Ioannidis JPA, Evangelou E. Systematic evaluation of the associations between environmental risk factors and dementia: An umbrella review of systematic reviews and meta-analyses. Alzheimers Dement. April 2017;13(4):406–18.
[17] Stoccoro A, Coppedè F. Role of epigenetics in Alzheimer’s disease pathogenesis. Neurodegener Dis Manag. Juni 2018;8(3):181–93.
[18] Solomon DA, Mitchell JC, Salcher-Konrad M-T, Vance CA, Mizielinska S. Review: Modelling the pathology and behaviour of frontotemporal dementia. Neuropathol Appl Neurobiol. Februari 2019;45(1):58–80.
[19]Dautaj A, Mandarà L, Tassi V, Dhuli K, Bertelli M. Genetic analysis of genes associated with Mendelian dementia. Acta Biomed. November 2020;91(13-S):e2020004.


[20] Duran-Aniotz C, Orellana P, Leon Rodriguez T, Henriquez F, Cabello V, Aguirre-Pinto MF, et al. Systematic Review: Genetic, Neuroimaging, and Fluids Biomarkers for Frontotemporal Dementia Across Latin America Countries [Internet]. Vol. 12, Frontiers in Neurology . 2021. Tersedia pada: https://www.frontiersin.org/articles/10.3389/fneur.2021.663407
[21] Mackenzie G, Will R. Creutzfeldt-Jakob disease: recent developments. F1000Research. 2017;6:2053.
[22] Custodio N, Wheelock A, Thumala D, Slachevsky A. Dementia in Latin America: Epidemiological Evidence and Implications for Public Policy. Front Aging Neurosci. 2017;9:221.
[23] Fogel BL. Genetic and genomic testing for neurologic disease in clinical practice. Handb Clin Neurol. 2018;147:11–22.
[24]Convery R, Mead S, Rohrer JD. Review: Clinical, genetic and neuroimaging features of frontotemporal dementia. Neuropathol Appl Neurobiol. Februari 2019;45(1):6–18.
[25] Ciani M, Bonvicini C, Scassellati C, Carrara M, Maj C, Fostinelli S, et al. The Missing Heritability of Sporadic Frontotemporal Dementia: New Insights from Rare Variants in Neurodegenerative Candidate Genes. Int J Mol Sci. Agustus 2019;20(16).
[26]Rolf B, Blue EE, Bucks S, Dorschner MO, Jayadev S. Genetic counseling for early onset and familial dementia: Patient perspectives on exome sequencing. J Genet Couns. Juni 2021;30(3):793–802.
[27] Mega A, Galluzzi S, Bonvicini C, Fostinelli S, Gennarelli M, Geroldi C, et al. Genetic counselling and testing for inherited dementia: single-centre evaluation of the consensus Italian DIAfN protocol. Alzheimers Res Ther. November 2020;12(1):152.

Downloads

Published

2023-09-20

Issue

Vol. 7 No. 2 (2023): September

Section

Artikel

Citation Check

License

Authors who publish with Indonesian Journal for Health Sciences (IJHS) agree to the following terms:

1. Copyright and License
The copyright of articles published in the Indonesian Journal for Health Sciences is transferred to and held by the journal/publisher. Authors agree to transfer the copyright of their accepted articles to the Indonesian Journal for Health Sciences. All published articles are distributed under a Creative Commons Attribution-ShareAlike (CC BY-SA) license. This license allows others to share, adapt, and build upon the work in any medium or format, including for commercial purposes, provided that appropriate credit is given to the original source and that any derivative works are distributed under the same license..

2. Author Rights
Authors are permitted and encouraged to share their work online (e.g., in institutional repositories, personal websites, or academic networking platforms) before and during the submission process, as this can lead to productive academic exchanges and increased citation of the published work. Authors may archive the pre-print, post-print, or publisher’s PDF version of their article with an acknowledgment of its initial publication in Indonesian Journal for Health Sciences.

3. Copyright Transfer Agreement
Indonesian Journal for Health Sciences requires authors to complete and sign a formal Copyright Transfer Agreement (CTA) form before publication. The form confirms that the submitted work is original, has not been published elsewhere, and that all authors agree to transfer the publication rights to the journal for the purpose of dissemination and indexing.
The form can be downloaded here

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.